![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Hoy Sheridan M.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.72, Iss.14, 2012-10, pp. : 1929-1950
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bendamustine: A Review of its Use in the Management of Indolent Non-Hodgkin Lymphoma
By Plosker Greg L. Carter Natalie J.
Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Rituximab for the Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia
Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. :